Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Similar documents
GENERAL NOTES: 2016 site of infection type of organism location of the patient

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Approach to pediatric Antibiotics

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

2016 Antibiotic Susceptibility Report

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

2015 Antibiotic Susceptibility Report

Antimicrobial Susceptibility Testing: Advanced Course

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Antibiotic Updates: Part II

Appropriate antimicrobial therapy in HAP: What does this mean?

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Antimicrobial susceptibility

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Rational management of community acquired infections

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

RCH antibiotic susceptibility data

Advanced Practice Education Associates. Antibiotics

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

EUCAST recommended strains for internal quality control

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Rational use of antibiotics

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Concise Antibiogram Toolkit Background

National Surveillance of Antimicrobial Resistance

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Antimicrobial Stewardship Strategy: Antibiograms

Intrinsic, implied and default resistance

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Antibiotic Usage Guidelines in Hospital

Dr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

number Done by Corrected by Doctor Dr.Malik

CUMULATIVE ANTIBIOGRAM

Intro Who should read this document 2 Key practice points 2 Background 2

Antimicrobial Chemotherapy

FOLLOWING BUNDLE ADMINISTERED WITHIN ONE HOUR.

Cipro for gram positive cocci in urine

Antimicrobial Susceptibility Patterns

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Responsible use of antibiotics

European Committee on Antimicrobial Susceptibility Testing

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS

number Done by Corrected by Doctor

CONTAGIOUS COMMENTS Department of Epidemiology

CLINICAL USE OF BETA-LACTAMS

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

** the doctor start the lecture with revising some information from the last one:

Antimicrobial Susceptibility Testing: The Basics

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

DRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Septicaemia Definitions 1

ESBL Positive E. coli and K. pneumoneae are Emerging as Major Pathogens for Urinary Tract Infection

National Antimicrobial Prescribing Survey

Acute Pyelonephritis POAC Guideline

European Committee on Antimicrobial Susceptibility Testing

Understanding the Hospital Antibiogram

General Approach to Infectious Diseases

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Guidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis)

Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Optimizing Selection of Empirical Antimicrobial Therapy in the Era of Precision Medicine

CONTAGIOUS COMMENTS Department of Epidemiology

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Cipro for klebsiella uti

your hospitals, your health, our priority PARC (Policy Approval and Ratification Committee) STANDARD OPERATING PROCEDURE:

Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Doxycycline for enterococcus

Transcription:

Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic treatment: ceftriaxone +/- amikacin RISK FACTORS FOR ESBL+ E coli Older age History of UTI Presence of urinary catheter History of recent urological surgery Recent intake of antibiotics

Another 2 d later Blood culture: Escherichia coli Urine culture: Escherichia coli Antibiogram: Amoxicillin R Amoxicillin/clavulanic acid S Amikacin S Ceftriaxone S Ceftazidime S Cotrimoxazole R Ciprofloxacin S Gentamicin R Meropenem S

Which treatment will you give now? PO amoxycillin IV amoxycillin PO amoxycillin-clavulanic acid IV ciprofloxacin PO ciprofloxacin IV ceftriaxone IV ceftriaxone + amikacin IV meropenem

Another 2 d later Antibiogram: Amoxicillin R Amoxicillin/clavulanic acid S Amikacin S Ceftriaxone S Ceftazidime S Cotrimoxazole R Ciprofloxacin S Gentamicin R Meropenem S IV ceftriaxone 2 g qd or IV ciprofloxacin 500 mg q12 If no more fever 48 h: PO ciprofloxacin 500 mg q12 Total duration 7-10 days

But imagine another patient Another antibiogram: Amoxicillin R Amoxicillin/clavulanic acid S Amikacin S Ceftriaxone R Ceftazidime R Cotrimoxazole R Ciprofloxacin R Gentamicin R Meropenem S

Which treatment will you give now? PO amoxycillin IV amoxycillin PO amoxycillin-clavulanic acid IV ciprofloxacin PO ciprofloxacin IV ceftriaxone IV ceftriaxone + amikacin IV meropenem

Amoxicillin R Amoxicillin/clavulanic acid S Amikacin S Ceftriaxone R Ceftazidime R Cotrimoxazole R Ciprofloxacin R Gentamicin R Meropenem S Ceftriaxone R suggest presence of ESBL = resistance for all beta-lactam drugs (exc. Carbapenem, cefepime) =often co-resistance to ciprofloxacin, gentamicin, cotrimoxazole Here you need to use Meropenem 1 g q8 x 10 d

Case 3 15 year old female student 10 d high fever, abdominal pain BP 82/43 mmhg RR 24/, O2 Sat 97%, temp 39.3 C Hb 11.9 g/dl WBC 7200/µl sgot/sgpt 91/28 Malaria smear negative CXR negative

2 days later Persisting high fever and abdominal pain Blood cultures show Gram negative bacilli

Another 2 days later Blood cultures Salmonella Typhi Antibiogram Ampicillin R Amoxycillin-clavulanic acid I Cotrimoxazole R Chloramphenicol R Ciprofloxacin R Ceftriaxone S

Which treatment do you give? PO amoxycillin PO Augmentin PO ciprofloxacin IV ceftriaxone IV imipenem IV vancomycin

Which treatment do you give? PO amoxycillin PO Augmentin PO ciprofloxacin IV ceftriaxone IV imipenem IV vancomycin

But imagine another typhoid patient: Blood cultures Salmonella Typhi Antibiogram Ampicillin R Amoxycillin-clavulanic acid I Cotrimoxazole R Chloramphenicol R Nalidixic acid S Ciprofloxacin S Ceftriaxone S

Which treatment do you give? PO amoxycillin PO Augmentin PO ciprofloxacin IV ceftriaxone IV imipenem IV vancomycin

Which treatment do you give? PO amoxycillin PO Augmentin PO ciprofloxacin IV ceftriaxone IV imipenem IV vancomycin

Salmonella Typhi If possible, treat with ciprofloxacin If nalidixic acid R cipro R Then: IV ceftriaxone 2 g qd x 10 d Or PO azithromycin 1000 mg d1, then 500 mg/d x 7 d

Case 4 40 y/o man Prey Veng History DMII (3years) Malaria in 1980 Liver abscess (4 & 2 months ago) Medication: herbal medicine Amoxicillin Diamicron. No known allergy His wife and 3 children are healthy

Evolution amoxycillin (2 w) no improvement Ceftriaxone + metronidazole (5d) no improvement Blood cultures: Burkholderia pseudomallei

How to treat? Continue IV ceftriaxone + metronidazole Switch to IV Augmentin Switch to IV ceftazidime Switch to IV cotrimoxazole Switch to IV chloramphenicol + amikacin other

How to treat? Continue IV ceftriaxone + metronidazole Switch to IV Augmentin Switch to IV ceftazidime Switch to IV cotrimoxazole Switch to IV chloramphenicol + amikacin other

Melioidosis: intensive phase IV ceftazidime 50mg/kg up to 2g q6 x minimum 10 days IF NO CEFTAZIDIME: IV Augmentin 20/5 mg/kg q4 at least 10 days OR IV/PO cotrimoxazole (IV or PO 8/40mg/kg q12 up to 320/1600mg q12) +/- doxycycline 2.5 mg/kg up to 100mg q12 (dose) OR IV ceftriaxone (at larger doses than usual 50mg/kg up to 2g qd) at least 10 days + cotrimoxazole (IV or PO 8/40mg/kg q12 up to 320/1600mg q12)

Melioidosis: continuation phase Cotrimoxazole 8/40mg/kg up to 320/1600mg q12 x at least 3 months (= 12 weeks) OR For children and pregnant women: Augmentin 20/5mg/kg up to 1500/375mg q8 x at least 3 months (=12 weeks) may need treatment for 6 months

Evolution Clinical improvement, no more fever on 08/06/10. 14.06.10: switch to Cotrimoxazole with Doxycyclin and discharge home Ambulatory follow up for Melioidosis treatment and diabetes: he was ok at followup on 26/07/10.

Interpretation of antibiograms

Step by step 1. Look for the name of the bacteria 2. Look for the first choice antibiotic 3. If S prescribe this 4. If R second choice antibiotic 5. If possible, de-escalate

1. Look for the name of the bacteria Is this a true pathogen (causing the disease) e.g. Staphylococcus aureus Choose antibiotics! E coli and other Gram negative bacilli Or is this more likely a contaminant e.g. Coagulase negative Staphylococci Bacillus Corynebacterium No antibiotics needed!!

2. Look for the first choice antibiotic Each bacterium has first choice antibiotics Best activity, smallest spectrum, Should be written in treatment guideline Staphylococcus aureus cloxacillin Pneumococ penicillin G Salmonella species ciprofloxacin E. coli ciprofloxacin, ampicillin, Augmentin

3. If the first choice AB shows S Then you prescribe the first choice AB! According to your local guidelines & availability With the smallest spectrum possible Dose according to the disease severity e.g. S aureus causing skin infection» Cloxacillin PO 500 mg q6 S aureus causing blood stream infection/sepsis» Cloxacillin IV 1-2 g q4-6

4. If the first choice shows R Use the second choice antibiotic As listed in guidelines Or: with known good activity against this bacterium AND with the smallest spectrum possible

Example1: Staphylococcus aureus Cloxacillin R (MRSA) Serious infection use vancomycin if possible Mild infection use cotrimoxazole (or lincomycin) if S

Example 2: E. coli Ampicillin R use Augmentin or ciprofloxacin Ciprofloxacin R use Augmentin (if S) or Ceftriaxone Augmentin R check if also Ceftriaxone R (likely ESBL+) use ciprofloxacin, cotrimoxazole (if S) if all other AB R: use meropenem (if available) Ceftriaxone R serious infections: use meropenem (if available) mild infections: use cotrimoxazole, ciprofloxacin (if S) UTI: use nitrofurantoin (if S) Use only meropenem if serious and if you have no other possibility

Beta-lactamases

ESBL Extended spectrum beta-lactamase Treatment options: Severe disease: carbapenem( meropenem or imipenem) amikacin (use ALWAYS in combination) Moderate disease: Is treatment necessary, is I&D alone enough, Check if you can use cotrimoxazole or ciprofloxacin Only if no other option use carbapenem UTI: nitrofurantoin (if S )

4. If possible, de-escalate: Treatment simplification/narrowing of microbiological spectrum Narrowing the spectrum Kill the bacteria as selectively as possible Use the least toxic, easiest and most affordable drug BROAD SPECTRUM ANTIBIOTIC NARROW SPECTRUM ANTIBIOTIC

Broad spectrum AB Ceftriaxone Amoxyclavulanate Piperacillin-tazobactam Meropenem Examples Narrow spectrum AB Cloxacillin (for Staphylococci) Ampicillin, penicillin (for Streptococci) Temocillin (for E. coli)

Examples of de-escalation Staphylococcus aureus, methicillin sensitive (MSSA) IV/PO flucloxacilline (Floxapen ) Streptococcus pneumoniae, penicillin susceptible S) IV Penicilline/amoxycilline Salmonella Typhi, ciprofloxacin sensitive ciprofloxacin, (azithromycin) E. coli: more difficult. Depends on antibiogram IV temocillin, PO ciprofloxacine, (IV/PO amoxyclavulanate)

Usual duration of treatment Bacteremia (blood stream infection): 10-14 days Typhoid fever: 7-10 days Community acquired pneumonia: 7 days UTI: 3-5 days 7 d if nitrofurantoin used Skin and soft tissue infection: 7 days Meningitis: 10-14 days 21 d if Streptococcus suis, S. aureus, Listeria, Pseudomonas) Osteomyelitis/septic arthritis: 4-6 weeks

Usual doses (1) Ampicillin For (suspected) endocarditis: 1-2 g q4-6 IV For mild/local infections: 1 g q8 PO Augmentin For respiratory tract: 1 g q8 PO For urinary/abdominal: 500 mg q6-8 PO For melioidosis: 1 g q4-6 IV Azithromycin For typhoid fever 500-1000 mg qd PO Cloxacillin For bacteremia/endocarditis: 1-2 g q4-6 IV For skin/soft tissue infection: 500 mg q6 PO

Usual doses (2) Ciprofloxacin: 500 mg q12 Cotrimoxazole For MRSA and Gram-negative infections: 5/25 mg/kg q12 For melioidosis: 8/40 mg/kg q12 Ceftriaxone For meningitis 2 g q12 For other indications 2 g qd Ceftazidime For melioidosis: 1 g q8 Meropenem: 1 g q8 (ONLY FOR SEVERE INFECTIONS) Nitrofurantoin: 100 mg q8 x 7 days (UTI ONLY)